Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04278651 · ClinicalTrials.gov registry record · Phase 4
Early Antenatal Support for Iron Deficiency Anemia
A Phase 4 study of Pregnancy Related and Anemia, Iron Deficiency, sponsored by Thomas Jefferson University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT04278651: Recruiting Phase 4 study of Pregnancy Related and Anemia, Iron Deficiency, sponsored by Thomas Jefferson University.
NCT04278651 is a Phase 4 study of Pregnancy Related and Anemia, Iron Deficiency that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 80 participants, below the 1,962-participant average among 99 other Pregnancy Related trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04278651, a Phase 4 study of Pregnancy Related and Anemia, Iron Deficiency, is actively recruiting participants, sponsored by Thomas Jefferson University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized, controlled multi-site trial of iron therapy in pregnancy. The purpose of this research is to see if second trimester initiation of intravenous (IV) iron therapy is better than oral iron therapy for treatment of anemia in pregnancy by improving blood count, quality of life and reducing side effects.
Primary Outcome
Change in hemoglboin at day 90 following treatment initiation
Conditions Studied
Interventions
- DRUG Ferumoxytol
- DRUG Ferrous Sulfate
Study Locations (1)
Pennsylvania
- Thomas Jefferson University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-09-29 |
| Est. Completion | 2026-12-30 |
| Phase | Phase 4 |
What NCT04278651 shows while recruiting
NCT04278651 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,962-participant average among 99 other Pregnancy Related trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 2 interventions - of which Ferumoxytol is the first listed.
NCT04278651 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04278651 about?
NCT04278651 is a clinical study titled "Early Antenatal Support for Iron Deficiency Anemia". This is a randomized, controlled multi-site trial of iron therapy in pregnancy. The purpose of this research is to see if second trimester initiation of intravenous (IV) iron therapy is better than oral iron therapy for treatment of anemia in pregnancy by improving blood count, quality of life and r...
What is the current status of trial NCT04278651?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2021-09-29. Estimated completion is 2026-12-30.
What conditions does trial NCT04278651 study?
This clinical trial studies the following conditions: Pregnancy Related, Anemia, Iron Deficiency, Anemia of Pregnancy.
What interventions are being tested in trial NCT04278651?
The interventions under investigation include: Ferumoxytol (DRUG), Ferrous Sulfate (DRUG).
Who is sponsoring clinical trial NCT04278651?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04278651 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04278651's enrollment target sits among peer trials
80 60th of 99 higher than 40 of 99 other Pregnancy Related trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Related trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease
RECRUITING · Phase 4
-
Perineal Massage Using A Pelvic Wand During Pregnancy
RECRUITING · Phase 4
-
Low Dose Aspirin for Preterm Preeclampsia Preventionmg/day Dose in High-risk Patients
ACTIVE NOT RECRUITING · Phase 4
-
Effects of Pregnancy-associated Hormones on THC Metabolism in Women
ACTIVE NOT RECRUITING · Phase 4
-
Misoprostol Dosing in BMI Greater Than 30
COMPLETED · Phase 4
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI